vyne share price forecast

Sunday, November 20, 2022 Edit

The 3 analysts offering 12-month price forecasts for Vyne Therapeutics Inc have a median target of 400 with a high estimate of 500 and a low estimate of 150. Get the latest VYNE stock forecast powered by the most important price indicators.

Vyne S Current Market Cap Presents An Attractive Opportunity Nasdaq Vyne Seeking Alpha

Based on the share price being below its 5 20 50 day exponential moving averages the current trend is considered strongly.

. VYNE Therapeutics stock forecast 2022. Wall Street Stock Market Finance report prediction for the future. VYNE Therapeutics stock price for 2022 May.

10 most volatile stocks in US Market. The average Vyne Therapeutics stock price prediction forecasts a potential upside of 50976 from the current VYNE share price of 025. Stock Price Forecast.

The current VYNE Therapeutics VYNE share price is 025. VYNE Open a Brokerage Account. The highest price in 2022 will be 165 the lowest price will be 074 and.

The highest analyst price target. VYNE Vyne Therapeutics Share Price. Losses were -7333 million -7131 less than in 2020.

What is VYNEs Earnings Per Share EPS. VYNE Therapeutics stock monthly and. According to 11 stock analysts the average 12-month stock price forecast for VYNE stock is 479 which predicts an increase of 183457.

Buy or sell VYNE Therapeutics stock. VYNE Therapeutics Stock Price Chart Technical Analysis. Stock forecast for tomorrow and next 5 days.

Vyne Therapeutics Inc Stock Forecast. VYNE Therapeutics Inc Stock Market info Recommendations. 10 least volatile stocks in US Market.

VYNE Therapeutics Inc. The consensus price target fell 21 to US900 with the analysts clearly concerned about the weaker revenue outlook and expectation of ongoing losses. Sectors Healthcare Pharmaceuticals Vyne Therapeutics.

NASDAQ Stock Exchange Healthcare Biotechnology. VYNE one year forecast. Get an edge in the market with our Menlo Therapeutics Inc.

VYNE share price prediction for 2022 2023 2024 2025 2026 and 2027. This is based on 1 Wall Streets Analysts 12-month price targets issued in the past 3 months. In 2021 VYNEs revenue was 1476 million a decrease of -2971 compared to the previous years 2099 million.

The average price target for VYNE Therapeutics is 150. The Score for VYNE is 24 which is 52 below its historic median score of 50 and infers higher risk than normal. VYNE is not significantly more volatile than the rest of.

Vyne Therapeutics Inc Vyne Stock Price Quote News Stock Analysis

Vyne Stock Price Forecast Should You Buy Vyne

Newa Stock Forecast Price News Newater Technology

N Predictions

Barron S February 1 2021 Pdf Stock Market Index Exchange Traded Fund

Vyne Youtube

Cruisin Connecticut Vyne Restaurant Middlebury Ct

Vyne Therapeutics Stock Nasdaq Vyne Quotes And News Summary Benzinga

What You Need To Know About The Vyne Therapeutics Inc Nasdaq Vyne Analyst Downgrade Today

Global Payment Orchestration Market Analysis Size

Global Acne Treatment Market Analysis By Acne Type Inflammatory And Non Inflammatory By Treatment Type Medication And Therapeutic Devices Size Trends With Impact Of Covid 19 And Forecast Up To 2025